newsfilter
← Latest News
GlobeNewswire·

Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum

David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry Panel on April 29th at 10:30 AM ET PHILADELPHIA, PA, April 26, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ:VLON), ("Vallon" or the "C